|
About the HER2 research - I learned a lot that I did not know about my disease at San Antonio. As the docs at the mentor sessions spoke of blocking pathways and such they talked about success against the HER1 and HER3 paths that tumors will find a way to utilize to get around Herceptin blocking the HER2. They now are finding ways to target these other pathways and limit and stunt the constant relapses that we Stage IV gals have to contend with.
The research is quite hopeful and I found that the best news is the goal of giving more than one monoclonal antibody to get patients to NED and keep them there. They seem to be trying to phase out chemo if possible! The nano-science presented was amazing and helped me to get inside some of the the onc's thinking, as they don't normally talk to patients on this complex level.
This just scratches the surface of what I gleaned. I will try to share more if I get some time to put my thoughts and notes together.
|